![John Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Xu was the founder of Jemincare Therapeutics Corp., founded in 2018, and served as Chief Executive Officer from 2018 to 2019.
Dr. Xu worked at Abpro Corp.
as Senior Vice President Strategic Alliances from 2017 to 2019.
Dr. Xu earned a doctorate from Zhongshan Hospital Fudan University, a graduate degree from Chicago Medical School, and an MBA from the University of Colorado Colorado Springs.
| Unternehmen | Position | Ende |
|---|---|---|
Jemincare Therapeutics Corp.
 Jemincare Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company focused on clinical development of therapeutics | Vorstandsvorsitzender | 01.10.2019 |
| ABPRO CORPORATION | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Develops antibody therapies | Health Technology |
Zhongshan Hospital Fudan University
 Zhongshan Hospital Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Colorado Springs
 University of Colorado Colorado Springs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jemincare Therapeutics Corp.
Jemincare Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company focused on clinical development of therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
